1.
Journal of Medical Postgraduates
;
(12): 768-772, 2018.
Article
in Chinese
| WPRIM
| ID: wpr-818060
ABSTRACT
Soluble urokinase-type plasminogen activator receptor(suPAR) , a new injury biomarker, is widely used in research of infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, etc. In recent years, suPAR has been suggested to play an important role in various renal diseases. This review focuses on studies of suPAR in renal diseases and update, which will provide new clues for the diagnosis and treatment of renal diseases.